Skip to main content
. 2009 Sep 24;3:507–521. doi: 10.2147/opth.s5778

Table 3.

MIC90 values for besifloxacin against common causes of bacterial conjunctivitis76,106

Bacterial strain Besifloxacin: MIC90 Comparator(s): MIC90
Susceptible S. aureusa 0.03–0.5 μg/mL N/A
Susceptible S. epidermidisa 0.03–0.5 μg/mL N/A
Susceptible S. pneumoniaea 0.03–0.5 μg/mL N/A
Susceptible H. influenzaea 0.03–0.5 μg/mL N/A
MRSA 0.06 μg/mL N/A
Vancomycin-intermediate S. aureus 2 μg/mL N/A
Methicillin/ciprofloxacin-resistant S. aureus 8 μg/mL N/A
Penicillin-resistant S. pneumoniae 0.12 μg/mL N/A
Levofloxacin-resistant S. pneumoniae 2 μg/mL N/A
H. influenzae with β-lactamase production 0.03 μg/mL N/A
β-lactamase–positive, ampicillin-resistant H. influenzae 0.12 μg/mL N/A
Ciprofloxacin-susceptible MSSA 0.06 μg/mL Moxifloxacin: 0.125μg/mL
Gatifloxacin: 0.25 μg/mL
Ciprofloxacin-resistant MSSA 2 μg/mL Moxifloxacin: 8 μg/mL
Gatifloxacin:>8 μ g/mL
Methicillin-susceptible S. epidermidis sensitive to ciprofloxacin 0.06 μg/mL Moxifloxacin: 0.125μg/mL
Gatifloxacin: 0.25 μg/mL
Methicillin-resistant S. epidermidis sensitive to ciprofloxacin 0.06 μg/mL Moxifloxacin: 0.125μg/mL
Gatifloxacin: 0.25 μg/mL
S. aureus parC S80Y + gyrA S84L double mutant 0.5 μg/mL Moxifloxacin: 0.5μg/mL
Ciprofloxacin: 32 μg/mL
S. pneumoniae parC S79Y + gyrA S81Y double mutant 1 μg/mL Moxifloxacin: 4μg/mL
Ciprofloxacin:64 μg/mL
a

Unpublished data Bausch & Lomb Inc.

Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus.